Dr. Jörg Taubel, CEO of Richmond Pharmacology, will be attending the EASL 2024 Annual Meeting and International Liver Congress. This event, taking place from 5th to 8th June2024 at the MiCo Milano Convention Centre in Milan, Italy, is a key gathering for hepatology experts.
If you would like to connect with Dr. Taubel during the event, please reach out to arrange a meeting.
Five Years Since a World-First CRISPR Breakthrough at Richmond Pharmacology
December 8, 2025
In November 2020, Richmond Pharmacology made medical history when a patient received the first-ever systemically delivered CRISPR therapy, using lipid nanoparticles to edit genes directly inside the human body.
Richmond Pharmacology will attend JSCPT 2025 in Tokyo, represented by their leadership team. Topics include early-phase studies, bridging studies between Europe and Asia, gene and RNA-based therapy development, and cross-border collaboration.
By clicking “Accept”, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts. View our Privacy Policy for more information.
.svg){kind=small}
.avif)
